Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 923 | 2018 |
Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: an adapted model AC Eliasson, L Krumlinde-Sundholm, K Shaw, C Wang Developmental medicine and child neurology 47 (4), 266-275, 2005 | 513 | 2005 |
Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular Pathology and the College … S Roy, C Coldren, A Karunamurthy, NS Kip, EW Klee, SE Lincoln, A Leon, ... The Journal of Molecular Diagnostics 20 (1), 4-27, 2018 | 456 | 2018 |
Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer GE Konecny, C Wang, H Hamidi, B Winterhoff, KR Kalli, J Dering, ... Journal of the National Cancer Institute 106 (10), dju249, 2014 | 374 | 2014 |
Integrated molecular characterization of uterine carcinosarcoma AD Cherniack, H Shen, V Walter, C Stewart, BA Murray, R Bowlby, X Hu, ... Cancer cell 31 (3), 411-423, 2017 | 365 | 2017 |
Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases M Allen, MM Carrasquillo, C Funk, BD Heavner, F Zou, CS Younkin, ... Scientific data 3 (1), 1-10, 2016 | 356 | 2016 |
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 331 | 2013 |
Genomic, pathway network, and immunologic features distinguishing squamous carcinomas JD Campbell, C Yau, R Bowlby, Y Liu, K Brennan, H Fan, AM Taylor, ... Cell reports 23 (1), 194-212. e6, 2018 | 293 | 2018 |
Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer EL Goode, MS Block, KR Kalli, RA Vierkant, W Chen, ZC Fogarty, ... JAMA oncology 3 (12), e173290-e173290, 2017 | 285 | 2017 |
An evaluation of adaptive surrogate modeling based optimization with two benchmark problems C Wang, Q Duan, W Gong, A Ye, Z Di, C Miao Environmental Modelling & Software 60, 167-179, 2014 | 249 | 2014 |
Restoration of visual function by enhancing conduction in regenerated axons F Bei, HHC Lee, X Liu, G Gunner, H Jin, L Ma, C Wang, TK Hensch, ... Cell 164 (1), 219-232, 2016 | 239 | 2016 |
Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma E Loeuillard, J Yang, ELN Buckarma, J Wang, Y Liu, C Conboy, ... The Journal of clinical investigation 130 (10), 5380-5396, 2020 | 214 | 2020 |
Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo J Meng, F Guo, H Xu, W Liang, C Wang, XD Yang Scientific reports 6 (1), 22390, 2016 | 213 | 2016 |
Comparative study on gastrointestinal microbiota of eight fish species with different feeding habits J Li, J Ni, J Li, C Wang, X Li, S Wu, T Zhang, Y Yu, Q Yan Journal of applied microbiology 117 (6), 1750-1760, 2014 | 203 | 2014 |
Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2 and RAD51C Status JM Cunningham, MS Cicek, NB Larson, J Davila, C Wang, MC Larson, ... Scientific reports 4 (1), 4026, 2014 | 158 | 2014 |
Method and system for retrieving advertisement information Y Li, H Zhu, J Liu, D Guo, L Zhou, Z Wang, ZZ Liu, J Yuan, C Wang, ... US Patent 7,788,216, 2010 | 157 | 2010 |
Method and apparatus for optimizing queries over vertically stored database L Ma, Y Pan, C Wang, Y Yan US Patent 7,987,179, 2011 | 143 | 2011 |
Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1. C Wang, G Yan, Y Zhang, X Jia, P Bu Neoplasma 62 (4), 541-549, 2015 | 131 | 2015 |
Development and evaluation of deep learning–based segmentation of histologic structures in the kidney cortex with multiple histologic stains CP Jayapandian, Y Chen, AR Janowczyk, MB Palmer, CA Cassol, ... Kidney international 99 (1), 86-101, 2021 | 129 | 2021 |
Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes S Kommoss, B Winterhoff, AL Oberg, GE Konecny, C Wang, SM Riska, ... Clinical Cancer Research 23 (14), 3794-3801, 2017 | 126 | 2017 |